Skip to main content

Clinical Trials › NCT05054140

Active, Not RecruitingPhase 2

Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis

Sponsored by Immunic AG

Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov
450
Target enrollment
6
U.S. states
Sep 2021
Start date
Jan 2025
Expected completion

Interventions / Treatments

IMU-838Placebo matching IMU-838

Conditions studied

Multiple Sclerosis

Where this trial is running (8 sites)

Florida3 sites
Coral Springs · Naples · Ormond Beach
Georgia1 site
Atlanta
Illinois1 site
Northbrook
Maryland1 site
Lutherville
Michigan1 site
Detroit
Albuquerque

MS centers in Florida

Compare treatment centers near a trial site by center type, providers and trials.

View Florida centers

More Phase 2 trials

Browse all Phase 2 MS trials
The app

Check out the MS Buddy app

Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.

Download on the App StoreGet it on Google Play